Fi3 Financial Advisors’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
7,891
-34,124
-81% -$507K 0.24% 41
2026
Q1
$646K Hold
42,015
0.19% 60
2025
Q4
$758K Hold
42,015
0.23% 46
2025
Q3
$677K Buy
42,015
+5,390
+15% +$78.8K 0.23% 40
2025
Q2
$399K Hold
36,625
0.14% 69
2025
Q1
$457K Hold
36,625
0.19% 50
2024
Q4
$725K Buy
36,625
+15,725
+75% +$174K 0.27% 38
2024
Q3
$171K Hold
20,900
0.07% 109
2024
Q2
$142K Buy
20,900
+700
+3% +$4.79K 0.06% 84
2024
Q1
$152K Buy
+20,200
New +$43K 0.07% 85

Other funds holding MESO

Fi3 Financial Advisors's MESO Position: Q2 2026 in Review

Fi3 Financial Advisors reduced its Mesoblast (MESO) stake by 81% in Q2 2026, selling an estimated $507K and leaving 7,891 shares worth $1.02M. The position accounts for 0.24% of the portfolio, ranked #41.

Fi3 Financial Advisors first reported a position in MESO in Q1 2024 and has held it in 10 quarters since. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Fi3 Financial Advisors held 7,891 shares of Mesoblast worth $1.02M as of Q2 2026.
  • Fi3 Financial Advisors sold 34,124 Mesoblast shares in Q2 2026, an estimated $507K.
  • Mesoblast made up 0.24% of Fi3 Financial Advisors's portfolio in Q2 2026, its #41 holding.
  • Fi3 Financial Advisors first reported a position in Mesoblast in Q1 2024 and has held it in 10 quarters since.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Fi3 Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.